Cancer chemotherapy Flashcards

1
Q

Combined vs Single agent

A

Originally single chemotherapeutic agents used to treat cancer until the early 1960’s.
Combination therapy coupled with more aggressive treatment regimen became popular in 1960’s.
Combination therapy led to increased remission, in terms of both patient numbers and length of remission time
More aggressive regimen results in increased side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do alkylating agents work? What do they target in DNA?

A

Alkylating agents are highly electrophilic compounds that react with nucleophiles to form strong covalent bonds. There are several nucleophilic groups in DNA such as N-1 and N-3 of adenine bases, N-3 of cytosine and in particular N-7 of guanine.

React/bind to guanine for example and cross link the chains = disrupt replication or transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of cancers are treated using alkylating agents?

A

used to treat a wide range of cancers including leukaemia, non-hodgkin lymphoma, Hodgkin disease, multiple myeloma, lung, breast, testicular and ovarian cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why can’t chlormethine (alkylating agent) be given orally?

A

Too reactive to survive oral administration - so given via IV

Treatment of Hodgkin’s lymphoma via multidrug regime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is Melphalan (alkylating agent) be given? What is it usually used for/

A

Less reactive so can be given orally. Mimics phenyl alanine.

Used for treatment of multiple myeloma, ovarian and breast cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cyclophosphamide (alkylating agent) is given as a prodrug, what happens to it when taken?

A

It is a prodrug but not toxic itself but it is metabolised in the liver by cytochrome P450 to the active agent.
It can be taken orally without any damage to the gut wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the mechanism of action of cytotoxic antibiotics

A

contain a planar aromatic or heteroaromatic ring system which can slip into the double helix of DNA and distort its structure. Once bound, the drug can inhibit the enzymes involved in the replication and transcription process. Examples include doxorubicin, epirubicin, daunorubicin, mitoxantrone and the bleomycins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why can’t anthracyclines (cytotoxic antibody) be given orally?

A

Orally inactive need to be given as IV

Can have cardio-toxic side effects and multi-drug resistance can develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain how Doxorubicin (Intercalating agent) works and where did it come from?

A

Was isolated from Streptomyces Peucetius & used to treat a wide range of solid tumours.

It approaches DNA via the major groove of the double helix and intercalates using the planar tricyclic system.
The charged amino group attached to the sugar is also important, as it forms an ionic bond with the -vely charged phospahte groups on the DNA backbone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does the Intercalating action result in?

A

Intercalation prevents the normal action of an enzyme called topoisomerase II. An enzyme essential to effective replication of DNA and to the mitosis process.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the second likely mechanism Doxorubicin proves harmful to DNA ?

A

A second mechanism by which doxorubicin can prove harmful to DNA involves the hydroxyquinone moiety which can chelate iron to form a doxorubicin-DNA-iron complex. Reactive oxygen species are then formed leading to single strand breaks in the DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain how anti-metabolites (enzyme targets) work?

A

These drugs a similarly structured as the naturally occurring purines and pyrimidines involved in nucleic acid synthesis.

Since they are mistaken by the cell for normal metabolites they have two modes of action:
Disrupt DNA synthesis by inhibiting key enzymes required for DNA synthesis (they inhibit purine and/or pyrimidine production) AND by becoming incorporated into the DNA and RNA to produce incorrect codes and cause strand breaks or premature chain terminations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give an example of an anti-metabolite and how it works?

A

Dihydrofolate reductase (DHFR) inhibitors
e.g. methotrexate
inhibit DHFR which is an essential enzyme in folate metabolism

DHFR is crucial in maintaining levels of the enzyme cofactor tetrahydrofolate FH4 - without this cofactor the synthesis of the DNA building block dTMP is aborted which in turn slows down DNA synthesis and cell division.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some of the side effects of methotrexate?

A

bone marrow suppression, mucositis and diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can we overcome the metabolic block caused methotrexate?

A

Give folinic acid
This is a tetrahydrofolate and therefore provides an alternative source for the synthesis of nucleic acids. This is important when high doses of methotrexate are used, as folinic acid can be administered to patients as a rescue from the toxic effect of the treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Another example of an anti-metabolite is an inhibitor of thymidylate synthase. How does this work? give an example

A

Stop thymidylate synthesis which stops DNA synthesis

Example: 5-Fluorouracil - works as a suicide substrate so binds irreversibly to the enzyme.

17
Q

How can resistance occur with using thymidylate synthase inhibitors/5-fluorouracil?

A

Resistance can occur if the cell produces excess quantities of dUMP to compete with the drug for the active site of the enzyme

18
Q

How do DNA polymerase inhibitors work? Give an example

A

DNA polymerases catalyse the synthesis of DNA using the four deoxyribonucleotide building blocks, dATP, dGTP, dCTP and dTTP.
For example cytarabine is an analogue of 2’-deoxycytidine. It is phosphorylated in the cell to the corresponding triphosphate (ara-CTP) which acts as a competitive inhibitor. In addition, ara-CTP can act as a substrate for DNA polymerases and become incorporated into the growing DNA chain. This can lead to chain termination or prevent replication of the modified DNA. All of these effects result in the inhibition of DNA synthesis and repair.

19
Q

What is cytarabine (DNA polymerase inhibitor) used for and how is it administered?

A

used intravenously for the treatment of a wide variety of leukaemias

20
Q

Give an example of a group that inhibit tubulin polymerisation (protein targets)

A

Vinca Alkaloids:

Vincristine
vinblastine
vindesine
vinorelbine

21
Q

What is Vincristine used for?

A

Vincristine is used in combination therapy to treat acute leukaemias, Hodgkin’s lymphoma, small-cell lung carcinoma and a variety of other tumours

22
Q

What is vinblastine used for?

A

Vinblastine has been used in combination therapies for the treatment of lymphomas, testicular cancer and ovarian cancer.

23
Q

What is vindesine used for?

A

Vindesine has been used in the treatment of various leukaemias and lymphomas.

24
Q

What is Vinorelbine used for?

A

Vinorelbine is widely used for the treatment of breast cancer and non-small-cell lung carcinomas

25
Q

Give an example of a group that are tubilin DEpolymerisation inhibitors

A
Taxanes
Paclitaxel (Taxol) is derived from the bark of yew trees.  It was first identified in 1971 following a screening programme for new anticancer agents carried out by the US National Cancer Institute.  It shows outstanding therapeutic activity against solid tumours and was approved for clinical use in 1992 for the treatment of breast and ovarian cancers.  Docetaxel is a semi-synthetic taxoid which was approved for the treatment of advanced breast cancer in 1996.  Both agents are in clinical trials for the treatment of other cancers.
26
Q

What is the mechanism of action of Paclitaxel and Docetaxel?

A

They bind to the β-subunit of tubulin (one of the two separate proteins that make up tubulin). Their binding accelerates polymerization and stabilizes the resultant microtubules, thus inhibiting depolymerization. As a result the cell division cycle is halted mainly at the G2/M stage. Apoptosis then takes place.

27
Q

When are sex hormones and hormone antagonists used?

Give examples of some that are used

A

Used against cancers which are hormone dependent - if the tumour requires a specific hormone to function then a hormone can be administered that has an opposing effect.

examples:
Glucocorticoids (e.g. prednisolone and prednisone used orally for the treatment of leukaemias and lymphomas).

Oestrogens (e.g. ethinylestradiol, diethylstilbestrol, to treat prostate cancer by inhibiting the production of lutenizing hormone and thus decrease the synthesis of testosterone).

28
Q

What type of cancer do Progestins (hormone-based therapy) treat? Give examples

A

e.g. medroxyprogesterone acetate and megestrol acetate, to treat advanced endometrial carcinoma that cannot be treated by surgery or radiation

29
Q

What type of cancer do Androgens (hormone-based therapy) treat? Give examples

A

e.g. fluoxymesterone and testosterone propionate to treat metastatic breast cancer

30
Q

What type of cancer do Antioestrogens (hormone-based therapy) treat? Give examples

A

e.g. tamoxifen and raloxifene to antagonize oestrogen receptors and prevent oestradiol from binding, for breast cancer

31
Q

What type of cancer do Aromatase inhibitors (hormone-based therapy) treat? Give examples

A

e.g. aminoglutethimide and 4-hydroxyandrostenedione (second line drug for the treatment of oestrogen-dependent breast cancer

32
Q

Cancer cells have unusual shapes and contain distinctive antigens. What are the 3 groups of monoclonal antibodies? Give examples of what they work on

A
  1. Trigger immune response to attack cancer cells.
    Rituximab to treat non Hodgkins lymphoma
    Alemtuzumab for chronic lymphocytic leukaemia
  2. Block signals related to cell division
    Trastuzumab (Herceptin) for breast cancer
    Cetuximab for advanced bowel cancer
  3. Deliver drugs or radiation to cancer cells
    Ibritumomab for non Hodgkins lymphoma